Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Experts are predicting strong results driven by the robust sales of Lilly's blockbuster treatments, particularly recent launches. However, there are also concerns about potential headwinds from g